Proteomic Profiling of Stem Cell Differentiation
Proteomic Profiling of Stem Cell Differentiation
批准号:
6889216
负责人:
Song Li
金额:
$15.51万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-05-01 至 2007-01-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Bone marrow mesenchymal stem cell (BMMSC) has potential to differentiate into different cell types. The long-term goal of this research is to control BMMSC differentiation in vitro and use BMMSC-derived smooth muscle cell (SMC) to construct tissue-engineered vascular grafts. The cyclic mechanical strain in the vessel wall and transforming growth factor 13(TGF-B) play important roles in SMC differentiation and vascular remodeling. The investigator has shown that both mechanical strain and TGF-I31 increase the expression of SMC markers in BMMSC. However, the underlying mechanisms and the proteomic changes of BMMSCs during differentiation are not well understood. Proteomic profiling provides a systematic and powerful approach to studying stem cell functions. The investigator hypothesizes: (1) BMMSC and its differentiation can be characterized by the expression of specific protein markers, and (2) mechanical strain and TGF-B] regulate BMMSC differentiation through distinct mechanisms and synergize the differentiation of BMMSCs into SMCs. Two specific aims are proposed in this exploratory/development study. In Aim 1, the investigator will determine the proteomic profile of BMMSC and identify potential markers of BMMSC. TGF-B] and other differentiation factors will be used to induce the proteome changes and differentiation of BMMSC. A comprehensive strategy using state-of-the-art technologies will be employed for proteome analysis. 2D gel electrophoresis and multidimensional liquid chromatography will be used for protein/peptide separation. Mass spectrometry will be used for protein identification and characterization. A reference map of BMMSC will be generated. The proteins only expressed in undifferentiated BMMSC will be identified. In Aim 2, the investigator will determine the proteome changes in BMMSC in response to mechanical strain and TGF-B. The proteins with changes in expression and post-translational modifications will be identified. Immobilized metal affinity capture will be employed for phosphopeptide enrichment. The global mechano-chemical signal transduction during BMMSC differentiation will be determined, and a map will be generated for the signaling pathways differentially regulated, shared, and synergized by mechanical strain and TGF-B]. Categorization and cluster analysis will be performed to correlate the proteins and signaling pathways. This study will advance our knowledge on BMMSC proteome and differentiation, and lead to more focused and in-depth biological studies in the future. The successful accomplishment of the goals will have high impact on stem cell engineering, and provide a rational basis for engineering BMMSC for vascular tissue repair.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Combination Therapy for Pancreatic Cancer
-
批准号:10581174
-
项目类别:
-
资助金额:$47.26万
-
财政年份:2023
-
负责人:Song Li
-
依托单位:
Nanoparticles-mediated combination therapy for breast cancer
-
批准号:10617544
-
项目类别:
-
资助金额:$51.62万
-
财政年份:2023
-
负责人:Song Li
-
依托单位:
Mechanopriming for cell engineering
-
批准号:10737574
-
项目类别:
-
资助金额:$50.84万
-
财政年份:2023
-
负责人:Song Li
-
依托单位:
Multimodal wireless electrical stimulation for tissue regeneration
-
批准号:10615764
-
项目类别:
-
资助金额:$47.23万
-
财政年份:2022
-
负责人:Song Li
-
依托单位:
Study of Interleukin 33 as a new immunotherapy of lung cancer
-
批准号:10703786
-
项目类别:
-
资助金额:$26.69万
-
财政年份:2022
-
负责人:Song Li
-
依托单位:
Regulation of cell reprogramming by matrix stiffness
-
批准号:10281141
-
项目类别:
-
资助金额:$32.48万
-
财政年份:2021
-
负责人:Song Li
-
依托单位:
Regulation of cell reprogramming by matrix stiffness
-
批准号:10491279
-
项目类别:
-
资助金额:$32.48万
-
财政年份:2021
-
负责人:Song Li
-
依托单位:
Regulation of cell reprogramming by matrix stiffness
-
批准号:10687264
-
项目类别:
-
资助金额:$32.47万
-
财政年份:2021
-
负责人:Song Li
-
依托单位:
Study of Interleukin 33 as a new immunotherapy of lung cancer
-
批准号:10442707
-
项目类别:
-
资助金额:$8.14万
-
财政年份:2019
-
负责人:Song Li
-
依托单位:
Study of Interleukin 33 as a new immunotherapy of lung cancer
-
批准号:10202507
-
项目类别:
-
资助金额:$35.54万
-
财政年份:2019
-
负责人:Song Li
-
依托单位:
Platelets-Mediated Delivery of Checkpoint Inhibitors for Post-Surgical Cancer Immunotherapy
-
批准号:10668316
-
项目类别:
-
资助金额:$39.49万
-
财政年份:2019
-
负责人:Song Li
-
依托单位:
Therapeutic microneedles for localized treatment of periodontal tissue
-
批准号:10008033
-
项目类别:
-
资助金额:$28.56万
-
财政年份:2019
-
负责人:Song Li
-
依托单位:
Platelets-Mediated Delivery of Checkpoint Inhibitors for Post-Surgical Cancer Immunotherapy
-
批准号:10206060
-
项目类别:
-
资助金额:$41.4万
-
财政年份:2019
-
负责人:Song Li
-
依托单位:
Platelets-Mediated Delivery of Checkpoint Inhibitors for Post-Surgical Cancer Immunotherapy
-
批准号:10426123
-
项目类别:
-
资助金额:$39.49万
-
财政年份:2019
-
负责人:Song Li
-
依托单位:
Study of Interleukin 33 as a new immunotherapy of lung cancer
-
批准号:10654777
-
项目类别:
-
资助金额:$43.35万
-
财政年份:2019
-
负责人:Song Li
-
依托单位:
Towards Glucose Transporter-Mediated Glucose-Responsive Insulin Delivery with Fast Response
-
批准号:10425401
-
项目类别:
-
资助金额:$41.88万
-
财政年份:2018
-
负责人:Song Li
-
依托单位:
Nanotherapeutics for Synergistic Targeting of Myc in Prostate Cancer
-
批准号:10063859
-
项目类别:
-
资助金额:$35.7万
-
财政年份:2017
-
负责人:Song Li
-
依托单位:
Nanotherapeutics for Synergistic Targeting of Myc in Prostate Cancer
-
批准号:10307546
-
项目类别:
-
资助金额:$34.98万
-
财政年份:2017
-
负责人:Song Li
-
依托单位:
In Situ Regeneration of Blood Vessel
-
批准号:9022513
-
项目类别:
-
资助金额:$42.34万
-
财政年份:2015
-
负责人:Song Li
-
依托单位:
Nanomicellar Formulation for Synergistic Targeting of Prostate Cancer
-
批准号:8530621
-
项目类别:
-
资助金额:$19.9万
-
财政年份:2013
-
负责人:Song Li
-
依托单位:
海外基金